Lymphatic filariasis elimination programme in Assam, India, needs change in mass drug administration strategy to target the focus of infection

Lymphatic filariasis elimination programme in Assam, India, needs change in mass drug administration strategy to target the focus of infection

Bibliographic Details
Main Author:	Abdul Mabood Khan
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2018-01-01
Series:	Indian Journal of Medical Research
Online Access:	http://www.ijmr.org.in/article.asp?issn=0971-5916;year=2018;volume=147;issue=1;spage=7;epage=10;aulast=Khan

Similar Items

Impact of mass drug administration for elimination of lymphatic filariasis in Nepal.
by: Chet Raj Ojha, et al.
Published: (2017-07-01)

National mass drug administration costs for lymphatic filariasis elimination.
by: Ann S Goldman, et al.
Published: (2007-01-01)

Elimination of lymphatic filariasis: current perspectives on mass drug administration
by: Gyapong JO, et al.
Published: (2018-03-01)

Mass drug administration for elimination of lymphatic filariasis: a discussion
Published: (2011-09-01)

Prevalence of lymphatic filariasis in a tea garden worker population of Dibrugarh (Assam), India after six rounds of mass drug administration
by: A M Khan, et al.
Published: (2015-01-01)

Strengthening of mass drug administration implementation is required to eliminate lymphatic filariasis from India: an evaluation study
by: Chandrakant Lahariya, et al.
Published: (2008-11-01)

Modeling the impact and costs of semiannual mass drug administration for accelerated elimination of lymphatic filariasis.
by: Wilma A Stolk, et al.
Published: (2013-01-01)

Coverage of mass drug administration for elimination of lymphatic filariasis in urban Nagpur, Central India: A mixed method study
by: Sitikantha Banerjee, et al.
Published: (2019-01-01)

A review of factors that influence individual compliance with mass drug administration for elimination of lymphatic filariasis.
by: Alison Krentel, et al.
Published: (2013-11-01)

Improved assessment of mass drug administration and health district management performance to eliminate lymphatic filariasis.
by: Carmen Maroto-Camino, et al.
Published: (2019-07-01)

The role of personal opinions and experiences in compliance with mass drug administration for lymphatic filariasis elimination in Kenya.
by: Doris W Njomo, et al.
Published: (2012-01-01)

Elimination of Lymphatic Filariasis: Mass Drug Administration in Endemic Areas of (Bidar District) Karnataka-2008
by: T S Ranganath, et al.
Published: (2012-01-01)

Population migration: implications for lymphatic filariasis elimination programmes.
by: K D Ramaiah
Published: (2013-01-01)

Knowledge on lymphatic filariasis and mass drug administration (MDA) programme in filaria endemic districts of Andhra Pradesh, India
by: K.N.M.B. Rao, et al.
Published: (2008-02-01)

Reduction in acute filariasis morbidity during a mass drug administration trial to eliminate lymphatic filariasis in Papua New Guinea.
by: Daniel J Tisch, et al.
Published: (2011-07-01)

Reaching endpoints for lymphatic filariasis elimination- results from mass drug administration and nocturnal blood surveys, South Gujarat, India.
by: Anjali Modi, et al.
Published: (2017-04-01)

Global programme to eliminate lymphatic filariasis: the processes underlying programme success.
by: Kazuyo Ichimori, et al.
Published: (2014-12-01)

Factors associated with the acceptance of mass drug administration for the elimination of lymphatic filariasis in Agusan del Sur, Philippines
by: Sison Stephanie, et al.
Published: (2008-05-01)

An evaluation of coverage and compliance of mass drug administration 2006 for elimination of lymphatic filariasis in endemic areas of Gujarat
by: Kumar Pradeep, et al.
Published: (2008-01-01)

Mass Drug Administration for Lymphatic Filariasis Elimination in Two Districts of North Karnataka: Coverage and Compliance Assessment
by: Huluvadi Shivalingaiah Anwith, et al.
Published: (2020-12-01)

Elimination of lymphatic filariasis in the Gambia.
by: Maria P Rebollo, et al.
Published: (2015-03-01)

Overview of PacELF—the Pacific Programme for the Elimination of Lymphatic Filariasis
by: Kazuyo Ichimori, et al.
Published: (2017-11-01)

A study on coverage, compliance and awareness about mass drug administration for elimination of lymphatic filariasis in a district of West Bengal, India
by: P. Ray Karmakar, K. Mitra, Anirban Chatterjee, P.K. Jana, S. Bhattacharya & S.K. Lahiri
Published: (2011-06-01)

A study on coverage and compliance of mass drug administration programme for elimination of filariasis in Udupi district, Karnataka India
by: Ashwini Kumar, et al.
Published: (2009-09-01)

SYSTEMATIC REVIEW ON IMPACT OF MASS DRUG ADMINISTRATION ON LYMPHATIC FILARIASIS PREVENTION
by: Mohd Fathulzhafran Mohamed Hanan, et al.
Published: (2021-09-01)

Information technology in morbidity management of human lymphatic filariasis—A promising tool in global programme for elimination of lymphatic filariasis
by: R Renuka Devi, et al.
Published: (2018-01-01)

Epidemiological and entomological evaluations after six years or more of mass drug administration for lymphatic filariasis elimination in Nigeria.
by: Frank O Richards, et al.
Published: (2011-10-01)

Global elimination of lymphatic filariasis: a "mass uprising of compassion".
by: David G Addiss
Published: (2013-01-01)

Challenges in mass drug administration for treating lymphatic filariasis in Papua, Indonesia
by: Bhullar Navneet, et al.
Published: (2010-08-01)

Global alliance for the elimination of lymphatic filariasis
by: S Das
Published: (2005-01-01)

Progress on elimination of lymphatic filariasis in Sierra Leone
by: Joseph B. Koroma, et al.
Published: (2018-06-01)

Increasing coverage in mass drug administration for lymphatic filariasis elimination in an urban setting: a study of Malindi Town, Kenya.
by: Doris W Njomo, et al.
Published: (2014-01-01)

Surveillance efforts after mass drug administration to validate elimination of lymphatic filariasis as a public health problem in Vanuatu
by: Fasihah Taleo, et al.
Published: (2017-06-01)

Lymphatic filariasis elimination endgame in an urban Indian setting: the roles of surveillance and residual microfilaremia after mass drug administration
by: Anjali Modi, et al.
Published: (2021-05-01)

Epidemiological assessment of eight rounds of mass drug administration for lymphatic filariasis in India: implications for monitoring and evaluation.
by: Subramanian Swaminathan, et al.
Published: (2012-01-01)

Coverage survey for assessing mass drug administration against lymphatic filariasis in Gulbarga district, Karnataka, India
by: B.G. Ranganath
Published: (2010-03-01)

Directly observed treatment increases drug compliance in lymphatic filariasis mass drug administration
by: Tutik Ida Rosanti, et al.
Published: (2016-08-01)

Cessation of mass drug administration for lymphatic filariasis in Zanzibar in 2006: was transmission interrupted?
by: Maria P Rebollo, et al.
Published: (2015-03-01)

The global programme to eliminate lymphatic filariasis: health impact after 8 years.
by: Eric A Ottesen, et al.
Published: (2008-10-01)

Safety and Tolerability of Mass Diethylcarbamazine and Albendazole Administration for the Elimination of Lymphatic Filariasis in Kenya: An Active Surveillance Study
by: Christabel Khaemba, et al.
Published: (2021-03-01)